EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated Fasting Glucagon in Adolescents with Combined IFG+IGT- Alpha-Cell Hyperactivity Independent of Beta-Cell Function

Thomas Pixner, Wanda Lauth, Katharina Mörwald, Julia Lischka, Julian Gomahr, Rasmus Stenlid, Max Bergauer, Lotte Forer, Sabine Geiersberger, Katharina Maruszczak, Anders Forslund, Christian-Heinz Anderwald und 6 weitere

Journal of the Endocrine Society · 10.11.2026

DOI: 10.1210/jendso/bvag262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 10.11.2026. Verfasst von Thomas Pixner und 17 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The exact role of glucagon in pediatric prediabetes and its progression to type-2-diabetes mellitus (T2D) remains unclear. Elevated fasting glucagon levels are believed to contribute to the transition from normoglycemia to overt diabetes. This study aimed to determine if higher fasting glucagon concentrations characterize distinct prediabetic subgroups within a cohort of adolescents with obesity or overweight.

Methods

Adolescents with obesity or overweight (n=208), median age 13.6 years (Q1:11.7;Q3:15.5 years), from the Beta-JUDO study were grouped according to their glycemic state following an Oral Glucose Tolerance Test as normal fasting glucose and normal glucose tolerance (NGM), impaired glucose tolerance (IGT), impaired fasting glucose (IFG), a combination of the previous two (IFG+IGT). Groups were analyzed for fasting glucagon, fasting insulin and indices of beta-cell function and insulin-sensitivity. Results for each prediabetic subgroup were compared to that in normoglycemic adolescents with obesity or overweight.

Results

Fasting glucagon was significantly increased in individuals with IFG+IGT (p<0.05). Median fasting glucagon levels were 44.2 ng/L (Q1:38.0;Q3:50.3 ng/L) compared to 35.4 ng/L (Q1:26.3;Q3:48.8 ng/L) in NGM; 39.1 ng/L (Q1:34.8;Q3:60.6 ng/L) in IGT and 37.6 ng/L (Q1:25.6;Q3:47.0 ng/L) in IFG. Hyperglucagonemia in IFG+IGT remained significant after Propensity Score Matching for oral Disposition Index (oDI), indicating similar beta-cell function and insulin-resistance (p<0.05).

Conclusion

These findings demonstrate a distinct alpha-cell dysfunction in adolescents with IFG+IGT, reflected by significantly elevated fasting glucagon, independent of beta-cell function, despite prevailing hyperglycemia.

Zitieren

APA

Pixner, T., Lauth, W., Mörwald, K., Lischka, J., Gomahr, J., Stenlid, R., Bergauer, M., Forer, L., Geiersberger, S., Maruszczak, K., Forslund, A., Anderwald, C., Manell, H., Aydin, B., Cadamuro, J., Rump, K., Weghuber, D., & Bergsten, P. (2026). Elevated Fasting Glucagon in Adolescents with Combined IFG+IGT- Alpha-Cell Hyperactivity Independent of Beta-Cell Function. Journal of the Endocrine Society. https://doi.org/10.1210/jendso/bvag262

Vancouver

Pixner T, Lauth W, Mörwald K, Lischka J, Gomahr J, Stenlid R, et al. Elevated Fasting Glucagon in Adolescents with Combined IFG+IGT- Alpha-Cell Hyperactivity Independent of Beta-Cell Function. Journal of the Endocrine Society. 2026. doi:10.1210/jendso/bvag262

BibTeX
@article{Pixner2026,
  author = {Pixner, Thomas and Lauth, Wanda and Mörwald, Katharina and Lischka, Julia and Gomahr, Julian and Stenlid, Rasmus and Bergauer, Max and Forer, Lotte and Geiersberger, Sabine and Maruszczak, Katharina and Forslund, Anders and Anderwald, Christian-Heinz and Manell, Hannes and Aydin, Banu and Cadamuro, Janne and Rump, Kirsten and Weghuber, Daniel and Bergsten, Peter},
  title = {Elevated Fasting Glucagon in Adolescents with Combined IFG+IGT- Alpha-Cell Hyperactivity Independent of Beta-Cell Function},
  journal = {Journal of the Endocrine Society},
  year = {2026},
  doi = {10.1210/jendso/bvag262}
}
Kostenlos starten →